Nanotechnology Now - Press Release: "Elsevier Business Intelligence's 'IN3 Medical Device 360° London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012 "

Home > Press > Elsevier Business Intelligence's 'IN3 Medical Device 360° London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Abstract:
Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announces an outstanding roster of presenting senior global investors for its 'IN3 Medical Device 360° London' medical technology investment and partnering conference, being held April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre, London Kensington.

Elsevier Business Intelligence's 'IN3 Medical Device 360° London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Bridgewater, NJ | Posted on April 6th, 2012

'IN3 Medical Device 360° London' will feature presentations by approximately two dozen early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership, developing innovative new technologies in the areas of cardiovascular biomaterials, cartilage repair, cancer staging, nanotechnology, neurostimulation, infection control, diagnostics, laparoscopic surgery and much more. Presenting companies to date include: AiMedics, Anethon, CellCoTec, Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products, N8 Medical, NUUBO, QSTREAM VASCULAR, Replication Medical, Sapiens Steering Brain Stimulation, SeamVad, Sensible Medical Innovations, Soft Tissue Regeneration, Specialty Scanners, Vantix, and Vascular Flow Technologies.

The conference also will feature an outstanding agenda of panels and networking sessions with industry thought leaders discussing pressing issues facing the global device industry in 2012 and beyond. Participating speakers include: Edward Andrle, VP, Business Development & Strategy, Sorin Group; Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips Healthcare; Aris Constantinides, Investment Director, NBGI Ventures; Bulend Corbacioglu, VP, Business Development and Licensing, Covidien; Townsend Goddard, Director, Business Development & Strategic Planning, Stryker; Victor Higgs, Managing Director, Applied Nanodetectors; Alan O'Connell, Partner, Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Stan Rabinovich, VP, Advanced Technology, Edwards LifeSciences; Thom Rasche, Partner, Earlybird Venture Capital; and Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director, ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Wellington Partners, Delta Partners, Peppermint VIP, and Family Office Fund. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email .

IN3 Medical Device 360° London will be held at the Millennium Gloucester Hotel & Conference Centre, London Kensington. Event co-sponsors to date include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

####

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

For more information, please click here

Contacts:
Kayleen Kell
949-797-7142

Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: